A study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a dietary form of a naturally occurring molecule called calcium alphaketoglutarate, or Ca-αKG, reduced lung tumor growth in female mice and activated genes associated with better outcomes in women with lung cancer. The researchers also found that Ca-αKG had the opposite effect in male mice, where it was associated with larger tumors and increased tumor-cell proliferation.

The findings, published in the journal Cell Reports, suggest that Ca-αKG may influence lung cancer primarily through epigenetic changes—chemical modifications that help control which genes are turned on or off—rather than by changing the ca...

A Husker research team’s latest research could open the door to broader use of a class of materials whose electrical properties may someday power next-generation electronics, high-density energy storage, improved computer memory and new strategies for cooling.

In a new paper published in Science, University of Nebraska–Lincoln researchers Xiaoshan Xu, Alexei Gruverman and Evgeny Tsymbal demonstrate that hafnium oxide—a tough, heat-resistant chemical compound used widely in modern electronics—is inherently antiferroelectric, a rare quality found in very few materials. Unlike hafnium oxide, also known as hafnia, many intrinsically antiferroelectric materials contain the toxin lead, which limits their widespread use.

The trio said the discovery will help settle a longstanding...

In the search for extraterrestrial life, it makes sense to first look for rocky planets with an atmosphere, like Earth. Without an atmosphere, a planet can’t have surface water. But of the more than 6,300 exoplanets cataloged thus far, the vast majority are not rocky, and only a handful of the rocky worlds appear to have an atmosphere.

In a study published in The Astrophysical Journal Letters, a group led by University of Chicago scientist Brandon Park Coy reports another: a rocky super-Earth 154 light-years away in the constellation Pisces...

A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.

The research is published in the journal Science Translational Medicine.

The drug, Kamuvudine K-9, is a derivative of HIVdrugs already approved for use in peop...